Not a subscriber? Click here to learn
more.
|
| Home | About Us | Resources | Archive | Free Reports | Market Window |
Investors Just Bailed on These Stocks – We're In!By
Thursday, October 26, 2017
U.S. tech stocks recently had their largest inflows in 38 weeks, as I wrote on Tuesday.
To me, that's a sign that my "Melt Up" thesis is in full swing – that investors finally love stocks. We could see incredible gains over the next 12 to 18 months... And you want to be in on it.
However, for maximum returns on my long-term investments – the ones I'll be holding long after the Melt Up – I don't want to buy what's loved. I want to buy what's "hated."
To find the bottom, I don't want to see record inflows from investors. I want to see record outflows.
Record outflows are a great sign to me that an investment is hated. Then I want to wait for the start of an uptrend. That's my basic recipe for finding a great long-term investment...
Last week – the same week that U.S. tech-stock funds attracted more than a billion dollars – Reuters reported some crazy news about Japanese stock flows.
"Japanese equities suffered their largest weekly outflows on record, losing $4.4 billion, with 86% of this related to redemptions from exchange-traded funds," Reuters said.
The article attempted to explain why the outflows happened:
Investors were taking profits before the election results. They all got out... And that gives us an opportunity. You see, Abe won the election this week...
In December 2012, I called Japanese stocks "The Number One Opportunity of 2013: Abe's Revenge." It was the headline in my True Wealth newsletter.
Back then, Abe had recently returned to office – back for "revenge" – after resigning in 2007. Abe made his comeback by promising to undo the mistakes he made in 2006, when he backed Japan's central bank in raising interest rates.
His new goal? To create massive inflation, and break Japan out of its long struggle with deflation for good.
As I explained in 2012...
That turned out to be exactly right... Shares of DXJ went from around $33 near the end of 2012 to around $50 at the end of 2013 – more than a 50% gain! (Our subscribers pocketed 62% gains on this trade, as we held it longer.) Now, we have the same setup conditions...
Abe was just re-elected. He will follow the same blueprint. We can expect the same outcome – higher stock prices, and a lower currency value.
My True Wealth subscribers are back in this trade... And they're already up 24% in less than a year.
Meanwhile, nobody else is interested... The shares outstanding of DXJ are at four-year lows. It's exactly what I like to see.
With the re-election of Abe ensuring higher stock prices and a weaker yen... with Japanese stocks hated by investors today... and with the uptrend in place... you haven't missed it yet.
Japanese stocks are hated and in an uptrend. We're in! What about you?
Good investing,
Steve
Further Reading:
U.S. tech stocks are loved today – and that means the Melt Up is finally here. But if you aren't prepared, what happens next might scare you. Learn what to expect right here: Money Flooded Into Stocks Last Week – Here's What to Do.
"When I look at investment opportunities, I pay more attention to what's 'hated,'" Steve writes. Right now, that strategy is pointing to another fantastic opportunity. Read more here: The Ultimate Buy Setup Right Now in This Asset.
Market NotesRECORD HIGHS FOR THIS HEALTH CARE GIANT Today, we see an established company steadily churning out gains...
Longtime readers know investing in "World Dominators" is one of the safest investing strategies on the planet. Anchored at the top of their industries, these companies have outstanding customer loyalty and brand recognition. Right now, another one of these elite businesses is thriving – health care giant Johnson & Johnson (JNJ).
Johnson & Johnson has been a leader in consumer health care products, medical devices, and pharmaceuticals for decades. Its brands include household names like Band-Aid, skin-care brands Neutrogena and Aveeno, Listerine mouthwash, Tylenol pain reliever, and allergy medicine Benadryl. You probably have Johnson & Johnson's products in your medicine cabinet at home.
These powerful brands can survive just about anything. And that means stable returns for investors. In the past year, shares have rallied nearly 25%, and they just hit a new all-time high. It's one more reason why you should invest in the best businesses in the world...
 |
Recent Articles
|
